| P50 | author | You-Ming Li | Q92873728 |
| | Yi-Peng Chen | Q121409284 |
| | Lin Zheng | Q121409309 |
| P2093 | author name string | Xi Jin | |
| | Yi-da Yang | |
| | Chuan-qing Xu | |
| P2860 | cites work | Global epidemiology of hepatitis B virus | Q28298592 |
| | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q29615686 |
| | Nonalcoholic fatty liver disease | Q29619354 |
| | Epidemiology of non-alcoholic fatty liver disease in China. | Q30373353 |
| | Global challenges in liver disease | Q33999114 |
| | The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. | Q34004939 |
| | Imaging of hepatic steatosis | Q34215183 |
| | Entecavir for the treatment of chronic hepatitis B infection | Q34612997 |
| | Sonography of diffuse liver disease | Q34823621 |
| | Viral and host causes of fatty liver in chronic hepatitis B | Q35010958 |
| | Nonalcoholic fatty liver disease: a clinical review | Q36042906 |
| | EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 |
| | Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). | Q37452716 |
| | Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors | Q43503939 |
| | Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. | Q44643929 |
| | An epidemiological survey of alcoholic liver disease in Zhejiang province | Q44667960 |
| | A 21-year experience with major hemorrhage after percutaneous liver biopsy | Q44773944 |
| | Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors | Q44786680 |
| | Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis | Q45788086 |
| | Body mass index and waist circumference in non-alcoholic fatty liver disease | Q46692912 |
| | Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis | Q46931227 |
| | A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. | Q46981468 |
| | Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? | Q47201124 |
| | Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation. | Q51570654 |
| | Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. | Q64936845 |
| | Ultrasonographical Diagnosis of Fatty Liver: Significance of the Liver-Kidney Contrast | Q72780863 |
| | Hepatitis C and steatosis | Q80572687 |
| | [The guideline of prevention and treatment for chronic hepatitis B (2010 version)] | Q83311491 |
| | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study | Q83505457 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| | entecavir | Q418586 |
| | chronic hepatitis | Q62019625 |
| P304 | page(s) | e34198 | |
| P577 | publication date | 2012-03-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. | |
| P478 | volume | 7 | |